Mike Tummino

Mike Tummino has extensive experience in the field of quality control. Mike currently holds the position of Director, Quality Control at Intellia Therapeutics, Inc., where they have been working since October 2021. Prior to this, they served as the Associate Director, QC at the same company since September 2019. Before joining Intellia Therapeutics, Inc., Mike worked at Agenus as an Associate Director from May 2018 and as a QC Manager since April 2013. Mike also gained experience at Bristol-Myers Squibb as a QC HPLC Lead from October 2010 to March 2013 and at BioVEX as a QC Supervisor from October 2007 to August 2010. Additionally, they worked at Repligen Corporation as a Senior QC Analyst from April 2007 to September 2007, at ACAMBIS as a QC Supervisor-Product Release from September 2001 to March 2007, at Genzyme as a Senior Research Associate in 1997, at AutoImmune as a QC Associate Scientist II from 1996 to 1997, and at Astra Pharmaceuticals as an Associate Scientist from 1992 to 1995. Mike Tummino's work experience demonstrates their expertise and dedication in the field of quality control.

Mike Tummino completed their Bachelor's degree in Biology & Environmental Science from Clark University. Following that, they pursued a Master of Education degree in Secondary Education at the University of Massachusetts Lowell. In addition, they obtained a certification in CPR/AED/First Aid from the American Heart Association. The specific months and years of obtaining the certification and the duration of their education at Clark University are not provided.